Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
Price Target
Average
--25.89%
Revenue Forecast
Estimate
77.38%
EBIT
Estimate
--141.73%
Net Income
Estimate
113.04%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Intra-Cellular Therapies, Inc.
Wall Street analysts predict an average 1-year price target for ITCI of $97.3 , with forecasts ranging from
a
low of
$74 to a high of $132 .
ITCI Lowest Price Target
Wall Street Target
74 USD
-43.63%
ITCI Average Price Target
Wall Street Target
97.3 USD
-25.89%
ITCI Highest Price Target
Wall Street Target
132 USD
0.56%
REVENUE FORECAST
Revenue Forecast Chart ITCI
EBIT FORECAST
EBIT Forecast Chart ITCI
NET INCOME FORECAST
Net Income Chart ITCI